Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0000902664-25-001334

Options or other derivatives

  • Director acquired 8,333,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Aghazadeh Behzad · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-28 Grant or award : show line 1 in the form Pre-funded Warrant (right to buy) +8,333,000 $2.40 $19,998,367 8,333,000 I
Loading xslF345X05/ownership.xml…